Dr Mohamed Bouattour

Spécialité

Onco-hépatologie (thématique, carninome hépatocellulaire, cholangiocarcinome, cancers hépatiques rare)

Hôpital

Hôpital Beaujon (Clichy)

Derniers articles

• Palliative Care Referral Practices and Impact on Survival of Patients Diagnosed With Advanced Hepatocellular Carcinoma. (1 nov. 2025)
• Correction: ESR Bridges: imaging and treatment of uncommon liver tumours-a multidisciplinary view. (17 oct. 2025)
• A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function score: The UCGI 41 HESTIA TRIAL DESIGN AND PRELIMINARY SAFETY Data. (1 oct. 2025)
• Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort. (1 oct. 2025)
• Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapy. (1 sept. 2025)